Mauro Daniel Spina Donadio

Claudin 18.2 as a New Biomarker in Gastric Cancer—What Should We Know?

Maria Cecília Mathias-Machado, Victor Hugo Fonseca de Jesus, Alexandre A. Jácome et al. · Cancers · 2024 · 48 citations · Full text

Medicine, Oncology, Pharmacology +17

Retrospective comparison of the efficacy and the toxicity of standard and modified FOLFIRINOX regimens in patients with metastatic pancreatic adenocarcinoma

Victor Hugo Fonseca de Jesus, Marcos Pedro Guedes Camandaroba, Mauro Daniel Spina Donadio et al. · Journal of Gastrointestinal Oncology · 2018 · 36 citations · Full text

Medicine, Oncology, Pharmacology +16

The efficacy of everolimus and sunitinib in patients with sporadic or germline mutated metastatic pancreatic neuroendocrine tumors

Jose Eduardo Nuñez, Mauro Daniel Spina Donadio, Duilio Rocha Filho et al. · Journal of Gastrointestinal Oncology · 2019 · 18 citations · Full text

Medicine, Oncology, Pharmacology +16

Germline pathogenic variants in patients with early-onset neuroendocrine neoplasms

Rachel P. Riechelmann, Mauro Daniel Spina Donadio, Victor Hugo Fonseca de Jesus et al. · Endocrine Related Cancer · 2023 · 12 citations

Medicine, Genetics, Oncology +17